Phase II Study on the Efficacy and Safety of the EP1 Receptor Antagonist ONO-8539 for Nonneurogenic Overactive Bladder Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II Study on the Efficacy and Safety of the EP1 Receptor Antagonist ONO-8539 for Nonneurogenic Overactive Bladder Syndrome

Published:2014-01 Issue:1 Volume:191 Page:253-260
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Chapple C.R.¹,Abrams P.²,Andersson K.-E.³,Radziszewski P.⁴,Masuda T.⁵,Small M.⁵,Kuwayama T.⁵,Deacon S.⁵

Affiliation:

1. Royal Hallamshire Hospital, Sheffield, United Kingdom

2. Southmead Hospital, Bristol Urological Institute, Bristol, United Kingdom

3. Wake Forest University School of Medicine, Winston-Salem, North Carolina

4. Department of Urology, Medical University of Warsaw, Warsaw, Poland

5. ONO Pharma Ltd., London, United Kingdom

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society;Abrams;Neurourol Urodyn,2002

2. Antimuscarinic mechanisms and the overactive detrusor: an update;Andersson;Eur Urol,2011

3. Muscarinic acetylcholine receptors in the urinary tract;Andersson;Handb Exp Pharmacol,2011

4. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?;Finney;BJU Int,2006

5. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis;Chapple;Eur Urol,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

2. Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis;European Urology Focus;2021-09

3. Eicosanoid Pathway Modulators: Prostaglandins, Prostacyclin, and Thromboxane;Burger's Medicinal Chemistry and Drug Discovery;2021-04-28

4. Placebo Response in Patients with Oral Therapy for Overactive Bladder: A Systematic Review and Meta-analysis;European Urology Focus;2021-03

5. PGE2 receptors in detrusor muscle: Drugging the undruggable for urgency;Biochemical Pharmacology;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3